83 FR 32671 - National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 83, Issue 135 (July 13, 2018)

Page Range		32671-32671
FR Document		2018-15046

Federal Register, Volume 83 Issue 135 (Friday, July 13, 2018)

[Federal Register Volume 83, Number 135 (Friday, July 13, 2018)]
[Notices]
[Page 32671]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2018-15046]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel; NIAID Clinical Trial Implementation 
Cooperative Agreement (U01).
    Date: August 7, 2018.
    Time: 11:00 a.m. to 1:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 5601 Fishers Lane, 
Rockville, MD 20892 (Telephone Conference Call).
    Contact Person: Chelsea D. Boyd, Ph.D., Scientific Review 
Officer, Scientific Review Program, DEA/NIAID/NIH/DHHS, 5601 Fishers 
Lane, MSC-9823, Rockville, MD 20852-9834, 240-669-2081, 
chelsea.boyd@nih.gov.

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)

    Dated: July 10, 2018.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2018-15046 Filed 7-12-18; 8:45 am]
BILLING CODE 4140-01-P

Federal Register / Vol. 83, No. 135 / Friday, July 13, 2018 / Notices 32671

DEPARTMENT OF HEALTH AND DEPARTMENT OF HEALTH AND provisions set forth in sections
HUMAN SERVICES HUMAN SERVICES 552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
National Institutes of Health National Institutes of Health the discussions could disclose
confidential trade secrets or commercial
Center For Scientific Review; Notice of National Institute of Allergy and property such as patentable material,
Closed Meetings Infectious Diseases; Notice of Closed and personal information concerning
Meeting individuals associated with the grant
Pursuant to section 10(d) of the applications, the disclosure of which
Federal Advisory Committee Act, as Pursuant to section 10(d) of the
Federal Advisory Committee Act, as would constitute a clearly unwarranted
amended, notice is hereby given of the invasion of personal privacy.
following meetings. amended, notice is hereby given of the
following meeting. Name of Committee: National Eye Institute
The meetings will be closed to the The meeting will be closed to the Special Emphasis Panel; NEI Audacious
public in accordance with the public in accordance with the Goals Initiative RFA on Translation-Enabling
provisions set forth in sections provisions set forth in sections Models (U24).
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Date: August 3, 2018.
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Time: 8:30 a.m. to 3:00 p.m.
as amended. The grant applications and as amended. The grant applications and Agenda: To review and evaluate grant
the discussions could disclose the discussions could disclose applications.
confidential trade secrets or commercial confidential trade secrets or commercial Place: Hilton Garden Inn Bethesda, 7301
property such as patentable material, property such as patentable material, Waverly Street, Bethesda, MD 20814.
and personal information concerning and personal information concerning Contact Person: Anne E. Schaffner, Ph.D.,
individuals associated with the grant individuals associated with the grant Chief, Scientific Review Branch, Division of
applications, the disclosure of which Extramural Research, National Eye Institute,
applications, the disclosure of which 5635 Fishers Lane, Suite 1300, MSC 9300,
would constitute a clearly unwarranted would constitute a clearly unwarranted
invasion of personal privacy. Bethesda, MD 20892–9300, (301) 451–2020,
invasion of personal privacy. aes@nei.nih.gov.
Name of Committee: Center for Scientific Name of Committee: National Institute of (Catalogue of Federal Domestic Assistance
Review Special Emphasis Panel; Member Allergy and Infectious Diseases Special Program Nos. 93.867, Vision Research,
conflict: AIDS and AIDS Related Research. Emphasis Panel; NIAID Clinical Trial National Institutes of Health, HHS)
Date: July 26, 2018. Implementation Cooperative Agreement
Time: 1:00 p.m. to 6:00 p.m. Dated: July 10, 2018.
(U01).
Agenda: To review and evaluate grant Natasha M. Copeland,
Date: August 7, 2018.
applications. Time: 11:00 a.m. to 1:00 p.m. Program Analyst, Office of Federal Advisory
Place: National Institutes of Health, 6701 Agenda: To review and evaluate grant Committee Policy.
Rockledge Drive, Bethesda, MD 20892 applications. [FR Doc. 2018–15045 Filed 7–12–18; 8:45 am]
(Telephone Conference Call). Place: National Institutes of Health, 5601 BILLING CODE 4140–01–P
Contact Person: Jingsheng Tuo, Ph.D., Fishers Lane, Rockville, MD 20892
Scientific Review Officer, Center for (Telephone Conference Call).
Scientific Review, National Institutes of Contact Person: Chelsea D. Boyd, Ph.D., DEPARTMENT OF HEALTH AND
Health, 6701 Rockledge Drive, Room 5207, Scientific Review Officer, Scientific Review HUMAN SERVICES
Bethesda, MD 20892, 301–451–8754, tuoj@ Program, DEA/NIAID/NIH/DHHS, 5601
nei.nih.gov. Fishers Lane, MSC–9823, Rockville, MD National Institutes of Health
Name of Committee: Center for Scientific 20852–9834, 240–669–2081, chelsea.boyd@
Review Special Emphasis Panel; PAR Panel: nih.gov. Center For Scientific Review; Notice of
Role of HIV on Renal, Urologic, (Catalogue of Federal Domestic Assistance Closed Meetings
Hematological and Metabolic Dysfunction. Program Nos. 93.855, Allergy, Immunology,
Date: August 1, 2018. and Transplantation Research; 93.856, Pursuant to section 10(d) of the
Time: 8:00 a.m. to 5:00 p.m. Microbiology and Infectious Diseases Federal Advisory Committee Act, as
Agenda: To review and evaluate grant Research, National Institutes of Health, HHS) amended, notice is hereby given of the
applications. Dated: July 10, 2018. following meetings.
Place: Renaissance Mayflower Hotel, 1127 The meetings will be closed to the
Natasha M. Copeland,
Connecticut Avenue NW, Washington, DC public in accordance with the
20036. Program Analyst, Office of Federal Advisory
Committee Policy. provisions set forth in sections
Contact Person: Dimitrios Nikolaos 552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
Vatakis, Ph.D., Scientific Review Officer, [FR Doc. 2018–15046 Filed 7–12–18; 8:45 am]
as amended. The grant applications and
Center for Scientific Review, National BILLING CODE 4140–01–P
Institutes of Health, 6701 Rockledge Drive,
the discussions could disclose
Room 3190, Bethesda, MD 20892, 301–827– confidential trade secrets or commercial
7480, dimitrios.vatakis@nih.gov. DEPARTMENT OF HEALTH AND property such as patentable material,
(Catalogue of Federal Domestic Assistance HUMAN SERVICES and personal information concerning
Program Nos. 93.306, Comparative Medicine; individuals associated with the grant
93.333, Clinical Research, 93.306, 93.333, National Institutes of Health applications, the disclosure of which
93.337, 93.393–93.396, 93.837–93.844, would constitute a clearly unwarranted
93.846–93.878, 93.892, 93.893, National National Eye Institute; Notice of Closed invasion of personal privacy.
sradovich on DSK3GMQ082PROD with NOTICES

Institutes of Health, HHS) Meeting Name of Committee: Center for Scientific
Dated: July 10, 2018. Pursuant to section 10(d) of the Review Special Emphasis Panel; PAR Panel:
Natasha M. Copeland, Amyloid Polymorphisms and Glycosylation
Federal Advisory Committee Act, as in Alzheimer’s, Disease—Rump.
Program Analyst, Office of Federal Advisory amended, notice is hereby given of the Date: July 17, 2018.
Committee Policy. following meeting. Time: 10:00 a.m. to 6:00 p.m.
[FR Doc. 2018–15041 Filed 7–12–18; 8:45 am] The meeting will be closed to the Agenda: To review and evaluate grant
BILLING CODE 4140–01–P public in accordance with the applications.

VerDate Sep<11>2014 16:47 Jul 12, 2018 Jkt 244001 PO 00000 Frm 00054 Fmt 4703 Sfmt 4703 E:\FR\FM\13JYN1.SGM 13JYN1

Document Created: 2018-07-13 01:05:05
Document Modified: 2018-07-13 01:05:05

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Dates		August 7, 2018.
FR Citation		83 FR 32671

83 FR 32671 - National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICESNational Institutes of Health

Federal Register Volume 83, Issue 135 (July 13, 2018)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health